RT @CochraneJapan: 早産児の罹患率と死亡率を低下させるための経鼻的持続陽圧呼吸療法の圧レベル https://t.co/WoBFt8qn2f
Nasal-CPAPの効果としては,まだデータが不十分なようです. High Flow Nasal Cannulaは入っていないよね? まだAbstructしか解放されてないから,どんなキーワードで検索したのか把握しておりません. CPAPやHFNCにおける哺乳機能とか,調べてみたい.
早産児の罹患率と死亡率を低下させるための経鼻的持続陽圧呼吸療法の圧レベル https://t.co/WoBFt8qn2f
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants - Bamat, N - 2021 | Cochrane Library https://t.co/XnXcJA0AaQ
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
RT @EBNEO: In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality i…
In a new @CochraneNeonate SRMA, @nbamat et al assess whether low vs high CPAP levels have an effect on morbidity and mortality in preterm infants. Full text: https://t.co/I6zNs7GXtp #neoEBM #EBNEOalerts #neotwitter https://t.co/1DN1SyirPX
RT @drbretty: 👀 Éclat trial not too far away… CPAP 10 (9-11) vs CPAP 7 (6-8) to prevent extubation failure in extremely preterm infants…
RT @CochraneColomb: ¿Cómo impacta la administración de niveles bajos versus moderados de #CPAP a recién nacidos #pretérmino en desenlaces d…
¿Cómo impacta la administración de niveles bajos versus moderados de #CPAP a recién nacidos #pretérmino en desenlaces de salud importantes? https://t.co/GQ16Pr2Oaa NUEVO: La revisión sistemática de @CochraneNeonate analiza la evidencia de 11 estudios. #ne
RT @CochraneLibrary: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP i…
RT @CochraneLibrary: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP i…
RT @CochraneLibrary: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP i…
How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact important health outcomes? https://t.co/kIVRywFPT4 NEW @CochraneNeonate systematic review looks at the the evidence of 11 studies. #
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @The_BPD_Collab: Congratulations to @nbamat on his recent @CochraneNeonate review on CPAP levels in preterm infants. We are grateful to…
RT @The_BPD_Collab: Congratulations to @nbamat on his recent @CochraneNeonate review on CPAP levels in preterm infants. We are grateful to…
RT @The_BPD_Collab: Congratulations to @nbamat on his recent @CochraneNeonate review on CPAP levels in preterm infants. We are grateful to…
Congratulations to @nbamat on his recent @CochraneNeonate review on CPAP levels in preterm infants. We are grateful to have Dr. Bamat serving on the Pharmacology Ad Hoc Working Group of the #BPDCollab. #neoebm #neoTwitter
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @CochraneUK: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact…
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @CochraneUK: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact…
RT @Libbyextra: 🤰🏻🤱🏼
RT @CochraneUK: How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact…
🤰🏻🤱🏼
How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact important health outcomes? https://t.co/dJSr0Lecxr New @CochraneNeonate systematic review looks at the evidence of 11 studies. #neon
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
RT @drbretty: 👀 Éclat trial not too far away… CPAP 10 (9-11) vs CPAP 7 (6-8) to prevent extubation failure in extremely preterm infants…
RT @drbretty: 👀 Éclat trial not too far away… CPAP 10 (9-11) vs CPAP 7 (6-8) to prevent extubation failure in extremely preterm infants…
👀 Éclat trial not too far away… CPAP 10 (9-11) vs CPAP 7 (6-8) to prevent extubation failure in extremely preterm infants @AnnaKidman3 @roseandtoby #neoEBM #neoTwitter
RT @nbamat: (1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who…
(1/2) Our Cochrane review on CPAP levels in preterm infants is now out. Many thanks to the great team at @CochraneNeonate who supported this through stops and starts. What did we find? That…. #neoEBM #neotwitter https://t.co/qYvPJjTei5
How does giving #preterm #infants low versus moderate‐high levels of nasal continuous positive airway pressure #CPAP impact important health outcomes? https://t.co/yHlomHSnxw NEW @CochraneNeonate systematic review looks at the evidence of 11 studies. #neo
New NNT→Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants https://t.co/NG8rqAJ2nL